JP2014118361A5 - - Google Patents

Download PDF

Info

Publication number
JP2014118361A5
JP2014118361A5 JP2012272828A JP2012272828A JP2014118361A5 JP 2014118361 A5 JP2014118361 A5 JP 2014118361A5 JP 2012272828 A JP2012272828 A JP 2012272828A JP 2012272828 A JP2012272828 A JP 2012272828A JP 2014118361 A5 JP2014118361 A5 JP 2014118361A5
Authority
JP
Japan
Prior art keywords
fsp
vaccination
tumors
msi
endometrium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012272828A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014118361A (ja
JP5890769B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2012272828A priority Critical patent/JP5890769B2/ja
Priority claimed from JP2012272828A external-priority patent/JP5890769B2/ja
Publication of JP2014118361A publication Critical patent/JP2014118361A/ja
Publication of JP2014118361A5 publication Critical patent/JP2014118361A5/ja
Application granted granted Critical
Publication of JP5890769B2 publication Critical patent/JP5890769B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012272828A 2012-12-13 2012-12-13 がんの予防及び治療のためのmsi特異的なフレームシフトペプチド(fsp) Active JP5890769B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2012272828A JP5890769B2 (ja) 2012-12-13 2012-12-13 がんの予防及び治療のためのmsi特異的なフレームシフトペプチド(fsp)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2012272828A JP5890769B2 (ja) 2012-12-13 2012-12-13 がんの予防及び治療のためのmsi特異的なフレームシフトペプチド(fsp)

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015149569A Division JP2016028025A (ja) 2015-07-29 2015-07-29 がんの予防及び治療のためのmsi特異的なフレームシフトペプチド(fsp)

Publications (3)

Publication Number Publication Date
JP2014118361A JP2014118361A (ja) 2014-06-30
JP2014118361A5 true JP2014118361A5 (cg-RX-API-DMAC10.html) 2015-10-15
JP5890769B2 JP5890769B2 (ja) 2016-03-22

Family

ID=51173521

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012272828A Active JP5890769B2 (ja) 2012-12-13 2012-12-13 がんの予防及び治療のためのmsi特異的なフレームシフトペプチド(fsp)

Country Status (1)

Country Link
JP (1) JP5890769B2 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3065327A1 (en) * 2017-06-02 2018-12-06 Arizona Board Of Regents On Behalf Of Arizona State University Universal cancer vaccines and methods of making and using same
BR112020000590A2 (pt) * 2017-07-12 2020-07-14 Nouscom Ag método de seleção de uma coleção, métodos para determinar as sequências de aminoácidos e para produzir uma cvp ou uma coleção de ácidos nucleicos, cvp, coleções de peptídeos de vacina, de ácidos nucleicos, de um ou mais vetores de expressão e coleção de vetores de expressão

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO315238B1 (no) * 1998-05-08 2003-08-04 Gemvax As Peptider som stammer fra leserammeforskyvingsmutasjoner i TBF<beta>II- eller BAX-genet, og farmasöytiske sammensetninger inneholdende disse,nukleinsyresekvenser som koder for slike peptider, plasmider og virusvektoreromfattende slikenukleinsy
AU2003232485A1 (en) * 2002-04-18 2003-10-27 Mtm Laboratories Ag Neopeptides and methods useful for detection and treatment of cancer

Similar Documents

Publication Publication Date Title
Liu et al. pH-sensitive nano-systems for drug delivery in cancer therapy
CY1118813T1 (el) Φαρμακευτικες συνθεσεις συν-κρυσταλλων τραμαδολης και κοξιμπων
BR112012024590A2 (pt) métodos de reforço da liberação de fármaco e da eficácia de agentes terapêuticos
IN2015DN00376A (cg-RX-API-DMAC10.html)
JP2016528162A5 (cg-RX-API-DMAC10.html)
EA201491299A1 (ru) Карбаматные соединения, их получение и применение
MX360179B (es) Complejo nanomolecular nts-poliplex que comprende el gen bdnf, para usarse en el tratamiento de la enfermedad de parkinson y composiciones farmacéuticas que lo contienen.
WO2012142529A3 (en) Clonal strains of attenuated vaccinia viruses and methods of use thereof
BR112014019459A8 (pt) Proteínas de ligação à cdim e usos das mesmas
EP2898064A4 (en) COMPOSITIONS AND METHODS FOR TREATMENT AND PREVENTION OF TISSUE INJURIES AND DISEASES
MX2011008430A (es) Metodos y composiciones para diagnostico y tratamiento del cancer.
JP2016519107A5 (cg-RX-API-DMAC10.html)
TR201909355T4 (tr) Oral uygulama için proton bağlayıcı polimerler.
EP2600769A4 (en) MEDICAL COMPUTER TOMOGRAPHY DEVICE
EA202091251A2 (ru) Новые способы иммунотерапии нескольких видов опухолей, в том числе рака желудочно-кишечного тракта и рака желудка
MX2019011965A (es) Composiciones de medicamentos a base de peptido de colageno y metodos y dispositivos para su produccion y uso.
EA201690004A1 (ru) Антитела против lamp1 и конъюгаты антитела и лекарственного средства, а также их применение
BR112012026224A2 (pt) métodos para tratar mal de alzheimer e para avaliar a eficácia de uma terapia
WO2020103961A3 (zh) 一种脑部肿瘤靶向肽及其应用
NZ700872A (en) Prophylactic or therapeutic agent for giant cell tumors occurring in bone and soft tissue or for chondrosarcoma
JP2016535794A5 (ja) 急速崩壊性固体剤形
EP2910634A4 (en) VACCINE FOR THE PREVENTION OF SWINE DISEASE
WO2009067520A3 (en) Peptides specific for hepatocellular carcinoma cells and applications thereof
JP2014526564A5 (cg-RX-API-DMAC10.html)
RU2014101462A (ru) Раковый антиген